Global Biopsy Devices Market Size study & Forecast, by Product Type (Guidance System, Needles, Guns, Reagents and Kits, Others), by Application (Medical Diagnosis, Scientific Research), by End Use (Hospital, Specialized Oncology Centres, Diagnostic Center

Global Biopsy Devices Market Size study & Forecast, by Product Type (Guidance System, Needles, Guns, Reagents and Kits, Others), by Application (Medical Diagnosis, Scientific Research), by End Use (Hospital, Specialized Oncology Centres, Diagnostic Centers, Research Institutes) and Regional Analysis, 2023-2030

Global Biopsy Devices Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% during the forecast period 2023-2030. Biopsy devices are medical instruments designed for the collection of tissue samples from the body for diagnostic purposes. These samples are typically examined under a microscope by a pathologist to determine the presence of diseases, identify abnormalities, or assess the nature of a particular condition. Biopsies are crucial for diagnosing various medical conditions, including cancer, infections, inflammatory diseases, and other abnormalities. The key factors driving the market growth are the rising prevalence of cancer, the growing aging population, rising demand for minimally invasive procedures, and increasing healthcare expenditure that is anticipated to support the market growth during the forecast period 2023-2030.

Additionally, the rising prevalence of breast cancer significantly supports the growth of the Biopsy Devices Market. As the incidence of breast cancer rises, the number of diagnostic procedures, including biopsies, also increases. Healthcare providers rely on biopsy devices to obtain tissue samples for definitive diagnosis and to determine the characteristics of the cancer that guide treatment planning. According to Cancer Tomorrow (WHO), in 2020 the number of breast cancer cases globally was 2.26 million and it is anticipated to reach 2.74 million by 2030. As a result, the rising breast cancer cases are anticipated to support the market growth. Moreover, growing advancements in biopsy technologies, such as the development of minimally invasive techniques, robotic-assisted biopsies, improved imaging guidance and supportive government initiatives aimed at improving healthcare infrastructure are anticipated to create lucrative opportunities for the market over the projected period. However, the availability of alternative techniques, high cost and fluctuating reimbursement policies stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Biopsy Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing incidence of cancer, the growing aging population, growing advances in diagnostic technologies, and the presence of key market players in the region. Whereas, the Asia Pacific is expected to grow with the highest CAGR over the forecast period, owing to factors such as the increasing incidence of breast cancer, rising breast cancer awareness campaigns and screening programs, growing demand for minimally invasive biopsy techniques, and rising healthcare expenditure.


Major market player included in this report are:
Becton, Dickinson and Company (US)
Cook Group
Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
Hologic, Inc. (US)
Argon Medical Devices Inc (US)
B. Braun Holding GmbH & Co. KG (Germany)
Cardinal Health, Inc. (US)
Olympus Corporation (Japan)
Boston Scientific Corporation (US)
FUJIFILM Holdings Corporation (Japan)

Recent Developments in the Market:
 In November 2020, NeoDynamics AB, a MedTech company committed to advancing the diagnosis and treatment of breast cancer, established a partnership with the Buckinghamshire Healthcare NHS Trust in London. This collaboration involves the implementation of NeoDynamics' NeoNavia pulse biopsy technology.

Global Biopsy Devices Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered – Product Type, Application, End Use, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Guidance System
Needles
Guns
Reagents and Kits
Others

By Application:
Medical Diagnosis
Scientific Research

By End Use:
Hospital
Specialized Oncology Centres
Diagnostic Centers
Research Institutes

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Becton, Dickinson and Company (US)
Cook Group
Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
Hologic, Inc. (US)
Argon Medical Devices Inc (US)
B. Braun Holding GmbH & Co. KG (Germany)
Cardinal Health, Inc. (US)
Olympus Corporation (Japan)
Boston Scientific Corporation (US)
FUJIFILM Holdings Corporation (Japan)

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.